News

Novo's new CEO faces sceptical investors with Wegovy US sales in focus
Novo Nordisk's new CEO Maziar Mike Doustdar has been handed the reins to turn around the Wegovy-making firm's flagging sales ...
Devdiscourse2d
Novo Nordisk Announces New CEO Amidst Weight-Loss Drug Competition
Novo Nordisk appoints Maziar Mike Doustdar as the new CEO to tackle falling sales and shares amid stiff competition in the ...
Novo Lifer Takes Job of Reviving Europe’s Weight-Loss Superstar
Maziar Mike Doustdar spent more than three decades quietly climbing the ranks of Novo Nordisk A/S, from office clerk through ...
Wegovy maker Novo's profit warning triggers $70 billion share rout
Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a ...
The Copenhagen Post1d
An international is the new CEO of Danish largest company: “I have embraced the Danish spirit, but we know no borders”
It’s not unusual for a non-national to be CEO, executive director, or president of a company in a country. “C-level” positions and top management roles are often international. However, when the ...
Devdiscourse1d
Pharma Industry Shaken: New Leadership and Tariff Challenges
Novo Nordisk's new CEO, Maziar Mike Doustdar, faces challenges in reviving waning sales and shares in the weight-loss drug ...